Used as a GH-stimulation diagnostic in some regions; studied as a secretagogue; not an FDA-approved therapy.
GHRP-2 (pralmorelin) is a potent growth-hormone-releasing peptide that, like the others in its family, activates the ghrelin receptor to drive GH release.
It produces strong, reliable GH pulses with relatively modest appetite, cortisol, and prolactin effects. That reliability is why, in some countries (notably Japan), it's actually used as an approved diagnostic agent to test how well a patient's pituitary can secrete growth hormone.
Outside that diagnostic role it is not an FDA-approved therapy; as a treatment it remains a research compound.
Searching the published record…
Searching the published record…
Searching the published record…
Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.